nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A4—Temozolomide—malignant glioma	0.0727	1	CbGbCtD
Vardenafil—PDE6H—pineal body—malignant glioma	0.0725	0.265	CbGeAlD
Vardenafil—PDE6H—retina—malignant glioma	0.0218	0.0797	CbGeAlD
Vardenafil—PDE6G—retina—malignant glioma	0.021	0.0767	CbGeAlD
Vardenafil—PDE5A—endothelium—malignant glioma	0.0171	0.0623	CbGeAlD
Vardenafil—PDE5A—blood vessel—malignant glioma	0.0157	0.0575	CbGeAlD
Vardenafil—PDE10A—telencephalon—malignant glioma	0.0131	0.0476	CbGeAlD
Vardenafil—PDE1B—telencephalon—malignant glioma	0.0129	0.0472	CbGeAlD
Vardenafil—PDE6H—central nervous system—malignant glioma	0.0114	0.0417	CbGeAlD
Vardenafil—Transient ischaemic attack—Temozolomide—malignant glioma	0.00939	0.0316	CcSEcCtD
Vardenafil—PDE6H—brain—malignant glioma	0.00906	0.0331	CbGeAlD
Vardenafil—PDE11A—brain—malignant glioma	0.00906	0.0331	CbGeAlD
Vardenafil—PDE5A—retina—malignant glioma	0.0083	0.0303	CbGeAlD
Vardenafil—Visual acuity reduced—Temozolomide—malignant glioma	0.00796	0.0268	CcSEcCtD
Vardenafil—PDE5A—telencephalon—malignant glioma	0.00764	0.0279	CbGeAlD
Vardenafil—PDE10A—central nervous system—malignant glioma	0.00742	0.0271	CbGeAlD
Vardenafil—PDE1B—central nervous system—malignant glioma	0.00735	0.0268	CbGeAlD
Vardenafil—PDE10A—cerebellum—malignant glioma	0.00725	0.0265	CbGeAlD
Vardenafil—PDE1B—cerebellum—malignant glioma	0.00719	0.0262	CbGeAlD
Vardenafil—Burning sensation—Carmustine—malignant glioma	0.00706	0.0238	CcSEcCtD
Vardenafil—Scotoma—Carmustine—malignant glioma	0.00646	0.0218	CcSEcCtD
Vardenafil—Scotoma—Temozolomide—malignant glioma	0.00624	0.021	CcSEcCtD
Vardenafil—PDE10A—brain—malignant glioma	0.00589	0.0215	CbGeAlD
Vardenafil—PDE1B—brain—malignant glioma	0.00584	0.0213	CbGeAlD
Vardenafil—Accidental injury—Carmustine—malignant glioma	0.00554	0.0187	CcSEcCtD
Vardenafil—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00501	0.0169	CcSEcCtD
Vardenafil—Neck pain—Carmustine—malignant glioma	0.00496	0.0167	CcSEcCtD
Vardenafil—Influenza like illness—Temozolomide—malignant glioma	0.0046	0.0155	CcSEcCtD
Vardenafil—PDE5A—central nervous system—malignant glioma	0.00434	0.0158	CbGeAlD
Vardenafil—Abnormal vision—Carmustine—malignant glioma	0.00428	0.0144	CcSEcCtD
Vardenafil—PDE5A—cerebellum—malignant glioma	0.00424	0.0155	CbGeAlD
Vardenafil—Abnormal vision—Temozolomide—malignant glioma	0.00413	0.0139	CcSEcCtD
Vardenafil—Eye pain—Carmustine—malignant glioma	0.00394	0.0133	CcSEcCtD
Vardenafil—Injury—Carmustine—malignant glioma	0.00387	0.0131	CcSEcCtD
Vardenafil—Eye pain—Temozolomide—malignant glioma	0.00381	0.0128	CcSEcCtD
Vardenafil—Amnesia—Carmustine—malignant glioma	0.00379	0.0128	CcSEcCtD
Vardenafil—Nasal congestion—Temozolomide—malignant glioma	0.00377	0.0127	CcSEcCtD
Vardenafil—Hot flush—Temozolomide—malignant glioma	0.00368	0.0124	CcSEcCtD
Vardenafil—Amnesia—Temozolomide—malignant glioma	0.00366	0.0123	CcSEcCtD
Vardenafil—Menopausal symptoms—Temozolomide—malignant glioma	0.00364	0.0123	CcSEcCtD
Vardenafil—PDE5A—brain—malignant glioma	0.00345	0.0126	CbGeAlD
Vardenafil—Face oedema—Carmustine—malignant glioma	0.00344	0.0116	CcSEcCtD
Vardenafil—Face oedema—Temozolomide—malignant glioma	0.00332	0.0112	CcSEcCtD
Vardenafil—Liver function test abnormal—Carmustine—malignant glioma	0.00329	0.0111	CcSEcCtD
Vardenafil—Breast disorder—Temozolomide—malignant glioma	0.00311	0.0105	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0031	0.0104	CcSEcCtD
Vardenafil—Dysphagia—Carmustine—malignant glioma	0.00308	0.0104	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00303	0.0102	CcSEcCtD
Vardenafil—Dysphagia—Temozolomide—malignant glioma	0.00297	0.01	CcSEcCtD
Vardenafil—Photosensitivity reaction—Temozolomide—malignant glioma	0.00271	0.00915	CcSEcCtD
Vardenafil—Infestation NOS—Temozolomide—malignant glioma	0.00265	0.00893	CcSEcCtD
Vardenafil—Infestation—Temozolomide—malignant glioma	0.00265	0.00893	CcSEcCtD
Vardenafil—Hepatobiliary disease—Temozolomide—malignant glioma	0.00251	0.00845	CcSEcCtD
Vardenafil—Sinusitis—Temozolomide—malignant glioma	0.00249	0.00838	CcSEcCtD
Vardenafil—Haemoglobin—Carmustine—malignant glioma	0.00247	0.00834	CcSEcCtD
Vardenafil—Haemorrhage—Carmustine—malignant glioma	0.00246	0.0083	CcSEcCtD
Vardenafil—Hypoaesthesia—Carmustine—malignant glioma	0.00245	0.00826	CcSEcCtD
Vardenafil—Connective tissue disorder—Carmustine—malignant glioma	0.00242	0.00815	CcSEcCtD
Vardenafil—Haemoglobin—Temozolomide—malignant glioma	0.00239	0.00806	CcSEcCtD
Vardenafil—Haemorrhage—Temozolomide—malignant glioma	0.00238	0.00802	CcSEcCtD
Vardenafil—Visual impairment—Carmustine—malignant glioma	0.00237	0.008	CcSEcCtD
Vardenafil—Hypoaesthesia—Temozolomide—malignant glioma	0.00237	0.00798	CcSEcCtD
Vardenafil—Pharyngitis—Temozolomide—malignant glioma	0.00236	0.00796	CcSEcCtD
Vardenafil—Urinary tract disorder—Temozolomide—malignant glioma	0.00235	0.00792	CcSEcCtD
Vardenafil—Connective tissue disorder—Temozolomide—malignant glioma	0.00234	0.00788	CcSEcCtD
Vardenafil—Urethral disorder—Temozolomide—malignant glioma	0.00233	0.00786	CcSEcCtD
Vardenafil—Eye disorder—Carmustine—malignant glioma	0.0023	0.00776	CcSEcCtD
Vardenafil—Visual impairment—Temozolomide—malignant glioma	0.00229	0.00773	CcSEcCtD
Vardenafil—Flushing—Carmustine—malignant glioma	0.00228	0.0077	CcSEcCtD
Vardenafil—Eye disorder—Temozolomide—malignant glioma	0.00222	0.00749	CcSEcCtD
Vardenafil—Tinnitus—Temozolomide—malignant glioma	0.00222	0.00748	CcSEcCtD
Vardenafil—Cardiac disorder—Temozolomide—malignant glioma	0.00221	0.00744	CcSEcCtD
Vardenafil—Flushing—Temozolomide—malignant glioma	0.00221	0.00744	CcSEcCtD
Vardenafil—Angiopathy—Temozolomide—malignant glioma	0.00216	0.00728	CcSEcCtD
Vardenafil—Mental disorder—Carmustine—malignant glioma	0.00216	0.00727	CcSEcCtD
Vardenafil—Immune system disorder—Temozolomide—malignant glioma	0.00215	0.00724	CcSEcCtD
Vardenafil—Mediastinal disorder—Temozolomide—malignant glioma	0.00214	0.00723	CcSEcCtD
Vardenafil—Erythema—Carmustine—malignant glioma	0.00214	0.00722	CcSEcCtD
Vardenafil—Mental disorder—Temozolomide—malignant glioma	0.00208	0.00703	CcSEcCtD
Vardenafil—Back pain—Carmustine—malignant glioma	0.00207	0.00699	CcSEcCtD
Vardenafil—Erythema—Temozolomide—malignant glioma	0.00207	0.00698	CcSEcCtD
Vardenafil—Vision blurred—Carmustine—malignant glioma	0.00202	0.00681	CcSEcCtD
Vardenafil—Back pain—Temozolomide—malignant glioma	0.002	0.00675	CcSEcCtD
Vardenafil—Vision blurred—Temozolomide—malignant glioma	0.00195	0.00658	CcSEcCtD
Vardenafil—Ill-defined disorder—Temozolomide—malignant glioma	0.00192	0.00648	CcSEcCtD
Vardenafil—Angioedema—Temozolomide—malignant glioma	0.00189	0.00638	CcSEcCtD
Vardenafil—Malaise—Temozolomide—malignant glioma	0.00187	0.0063	CcSEcCtD
Vardenafil—Vertigo—Temozolomide—malignant glioma	0.00186	0.00627	CcSEcCtD
Vardenafil—Convulsion—Carmustine—malignant glioma	0.00186	0.00626	CcSEcCtD
Vardenafil—Palpitations—Temozolomide—malignant glioma	0.00183	0.00617	CcSEcCtD
Vardenafil—Chest pain—Carmustine—malignant glioma	0.00182	0.00615	CcSEcCtD
Vardenafil—Myalgia—Carmustine—malignant glioma	0.00182	0.00615	CcSEcCtD
Vardenafil—Anxiety—Carmustine—malignant glioma	0.00182	0.00613	CcSEcCtD
Vardenafil—Convulsion—Temozolomide—malignant glioma	0.00179	0.00605	CcSEcCtD
Vardenafil—Myalgia—Temozolomide—malignant glioma	0.00176	0.00594	CcSEcCtD
Vardenafil—Arthralgia—Temozolomide—malignant glioma	0.00176	0.00594	CcSEcCtD
Vardenafil—Anxiety—Temozolomide—malignant glioma	0.00176	0.00592	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00175	0.0059	CcSEcCtD
Vardenafil—Discomfort—Temozolomide—malignant glioma	0.00174	0.00587	CcSEcCtD
Vardenafil—Infection—Carmustine—malignant glioma	0.00174	0.00586	CcSEcCtD
Vardenafil—Dry mouth—Temozolomide—malignant glioma	0.00172	0.00581	CcSEcCtD
Vardenafil—Tachycardia—Carmustine—malignant glioma	0.00171	0.00575	CcSEcCtD
Vardenafil—Anaphylactic shock—Temozolomide—malignant glioma	0.00169	0.0057	CcSEcCtD
Vardenafil—Infection—Temozolomide—malignant glioma	0.00168	0.00566	CcSEcCtD
Vardenafil—Nervous system disorder—Temozolomide—malignant glioma	0.00166	0.00559	CcSEcCtD
Vardenafil—Skin disorder—Temozolomide—malignant glioma	0.00164	0.00553	CcSEcCtD
Vardenafil—Hypotension—Carmustine—malignant glioma	0.00163	0.00551	CcSEcCtD
Vardenafil—Hyperhidrosis—Temozolomide—malignant glioma	0.00163	0.00551	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00159	0.00537	CcSEcCtD
Vardenafil—Insomnia—Carmustine—malignant glioma	0.00158	0.00533	CcSEcCtD
Vardenafil—Paraesthesia—Carmustine—malignant glioma	0.00157	0.00529	CcSEcCtD
Vardenafil—Dyspnoea—Carmustine—malignant glioma	0.00156	0.00526	CcSEcCtD
Vardenafil—Somnolence—Carmustine—malignant glioma	0.00155	0.00524	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00154	0.00519	CcSEcCtD
Vardenafil—Insomnia—Temozolomide—malignant glioma	0.00153	0.00515	CcSEcCtD
Vardenafil—Paraesthesia—Temozolomide—malignant glioma	0.00152	0.00512	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Carmustine—malignant glioma	0.00151	0.00509	CcSEcCtD
Vardenafil—Dyspnoea—Temozolomide—malignant glioma	0.00151	0.00508	CcSEcCtD
Vardenafil—Somnolence—Temozolomide—malignant glioma	0.0015	0.00507	CcSEcCtD
Vardenafil—Pain—Carmustine—malignant glioma	0.0015	0.00504	CcSEcCtD
Vardenafil—Dyspepsia—Temozolomide—malignant glioma	0.00149	0.00502	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00146	0.00492	CcSEcCtD
Vardenafil—Pain—Temozolomide—malignant glioma	0.00145	0.00487	CcSEcCtD
Vardenafil—Feeling abnormal—Carmustine—malignant glioma	0.00144	0.00486	CcSEcCtD
Vardenafil—Gastrointestinal pain—Carmustine—malignant glioma	0.00143	0.00482	CcSEcCtD
Vardenafil—Feeling abnormal—Temozolomide—malignant glioma	0.00139	0.0047	CcSEcCtD
Vardenafil—Abdominal pain—Carmustine—malignant glioma	0.00138	0.00466	CcSEcCtD
Vardenafil—Gastrointestinal pain—Temozolomide—malignant glioma	0.00138	0.00466	CcSEcCtD
Vardenafil—CYP3A4—central nervous system—malignant glioma	0.00135	0.00494	CbGeAlD
Vardenafil—Abdominal pain—Temozolomide—malignant glioma	0.00134	0.0045	CcSEcCtD
Vardenafil—Hypersensitivity—Carmustine—malignant glioma	0.00129	0.00434	CcSEcCtD
Vardenafil—Asthenia—Carmustine—malignant glioma	0.00125	0.00423	CcSEcCtD
Vardenafil—Hypersensitivity—Temozolomide—malignant glioma	0.00125	0.0042	CcSEcCtD
Vardenafil—Asthenia—Temozolomide—malignant glioma	0.00121	0.00409	CcSEcCtD
Vardenafil—Diarrhoea—Carmustine—malignant glioma	0.0012	0.00403	CcSEcCtD
Vardenafil—Pruritus—Temozolomide—malignant glioma	0.0012	0.00403	CcSEcCtD
Vardenafil—Dizziness—Carmustine—malignant glioma	0.00116	0.0039	CcSEcCtD
Vardenafil—Diarrhoea—Temozolomide—malignant glioma	0.00116	0.0039	CcSEcCtD
Vardenafil—Dizziness—Temozolomide—malignant glioma	0.00112	0.00377	CcSEcCtD
Vardenafil—Vomiting—Carmustine—malignant glioma	0.00111	0.00375	CcSEcCtD
Vardenafil—Rash—Carmustine—malignant glioma	0.0011	0.00372	CcSEcCtD
Vardenafil—Dermatitis—Carmustine—malignant glioma	0.0011	0.00371	CcSEcCtD
Vardenafil—Headache—Carmustine—malignant glioma	0.0011	0.00369	CcSEcCtD
Vardenafil—Vomiting—Temozolomide—malignant glioma	0.00107	0.00362	CcSEcCtD
Vardenafil—Rash—Temozolomide—malignant glioma	0.00107	0.00359	CcSEcCtD
Vardenafil—Dermatitis—Temozolomide—malignant glioma	0.00106	0.00359	CcSEcCtD
Vardenafil—Headache—Temozolomide—malignant glioma	0.00106	0.00357	CcSEcCtD
Vardenafil—Nausea—Carmustine—malignant glioma	0.00104	0.0035	CcSEcCtD
Vardenafil—Nausea—Temozolomide—malignant glioma	0.001	0.00338	CcSEcCtD
Vardenafil—PDE1B—Signaling Pathways—JAG1—malignant glioma	0.000137	0.000384	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH3—malignant glioma	0.000136	0.000382	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PDGFRA—malignant glioma	0.000136	0.000382	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-A—malignant glioma	0.000136	0.000381	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FBXW7—malignant glioma	0.000134	0.000376	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT2—malignant glioma	0.000134	0.000375	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EGFR—malignant glioma	0.000133	0.000373	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PDGFB—malignant glioma	0.000133	0.000372	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGFR1—malignant glioma	0.000132	0.00037	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CD—malignant glioma	0.000132	0.000369	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BDKRB2—malignant glioma	0.000131	0.000369	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—AKT1—malignant glioma	0.000131	0.000369	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—F2—malignant glioma	0.000131	0.000367	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—malignant glioma	0.000131	0.000366	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PTEN—malignant glioma	0.00013	0.000365	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PIK3CA—malignant glioma	0.000129	0.000363	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MDM2—malignant glioma	0.000129	0.000362	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RAF1—malignant glioma	0.000129	0.00036	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CD—malignant glioma	0.000128	0.00036	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ERBB2—malignant glioma	0.000127	0.000357	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000127	0.000356	CbGpPWpGaD
Vardenafil—PDE6G—Disease—STAT3—malignant glioma	0.000127	0.000355	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT2—malignant glioma	0.000126	0.000354	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF2—malignant glioma	0.000126	0.000354	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—KRAS—malignant glioma	0.000126	0.000352	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CB—malignant glioma	0.000125	0.000352	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HLA-A—malignant glioma	0.000125	0.000352	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TERT—malignant glioma	0.000125	0.000352	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CG—malignant glioma	0.000125	0.000351	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PTPN11—malignant glioma	0.000123	0.000345	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF2—malignant glioma	0.000123	0.000345	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PDGFB—malignant glioma	0.000122	0.000343	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH2—malignant glioma	0.000122	0.000343	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGFR1—malignant glioma	0.000122	0.000341	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CD—malignant glioma	0.000121	0.00034	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCL8—malignant glioma	0.000121	0.000338	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HIF1A—malignant glioma	0.00012	0.000336	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KNG1—malignant glioma	0.00012	0.000335	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BAD—malignant glioma	0.000118	0.000331	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MDM2—malignant glioma	0.000118	0.000331	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—malignant glioma	0.000118	0.00033	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RAF1—malignant glioma	0.000118	0.00033	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—malignant glioma	0.000116	0.000327	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ERBB2—malignant glioma	0.000116	0.000326	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CAV1—malignant glioma	0.000116	0.000325	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PIK3CA—malignant glioma	0.000115	0.000324	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CASP3—malignant glioma	0.000115	0.000324	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2—malignant glioma	0.000115	0.000323	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EGFR—malignant glioma	0.000115	0.000323	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MDM2—malignant glioma	0.000115	0.000322	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CB—malignant glioma	0.000115	0.000322	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD80—malignant glioma	0.000115	0.000321	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT2—malignant glioma	0.000115	0.000321	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RAF1—malignant glioma	0.000115	0.000321	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NTRK1—malignant glioma	0.000114	0.00032	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ERBB2—malignant glioma	0.000113	0.000318	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGF—malignant glioma	0.000113	0.000317	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—IDH2—malignant glioma	0.000113	0.000317	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PTPN11—malignant glioma	0.000112	0.000315	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CB—malignant glioma	0.000112	0.000314	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—KRAS—malignant glioma	0.000111	0.000311	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCL8—malignant glioma	0.00011	0.000309	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CD—malignant glioma	0.00011	0.000309	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BAD—malignant glioma	0.000109	0.000306	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—malignant glioma	0.000109	0.000306	CbGpPWpGaD
Vardenafil—PDE6G—Disease—KRAS—malignant glioma	0.000109	0.000305	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PTEN—malignant glioma	0.000108	0.000304	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOTCH1—malignant glioma	0.000108	0.000303	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCL8—malignant glioma	0.000107	0.000301	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000106	0.000298	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP3—malignant glioma	0.000106	0.000297	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD80—malignant glioma	0.000106	0.000297	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—malignant glioma	0.000106	0.000297	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EGFR—malignant glioma	0.000106	0.000297	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CB—malignant glioma	0.000106	0.000296	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APC—malignant glioma	0.000106	0.000296	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CASP3—malignant glioma	0.000106	0.000296	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2—malignant glioma	0.000105	0.000296	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN2B—malignant glioma	0.000105	0.000295	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT2—malignant glioma	0.000105	0.000294	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGF—malignant glioma	0.000104	0.000293	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—malignant glioma	0.000104	0.000291	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTPN11—malignant glioma	0.000104	0.000291	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CASP3—malignant glioma	0.000103	0.000289	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2—malignant glioma	0.000103	0.000288	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTK2—malignant glioma	0.000102	0.000286	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—PIK3CA—malignant glioma	0.000102	0.000286	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCL8—malignant glioma	0.000102	0.000285	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CD—malignant glioma	0.000101	0.000282	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HES1—malignant glioma	0.0001	0.000281	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PIK3CA—malignant glioma	9.99e-05	0.00028	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—KRAS—malignant glioma	9.99e-05	0.00028	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—malignant glioma	9.98e-05	0.00028	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NCOR1—malignant glioma	9.96e-05	0.000279	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BRAF—malignant glioma	9.93e-05	0.000278	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PTEN—malignant glioma	9.92e-05	0.000278	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—malignant glioma	9.86e-05	0.000277	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—RAF1—malignant glioma	9.83e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—malignant glioma	9.79e-05	0.000275	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—malignant glioma	9.72e-05	0.000273	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—IDH1—malignant glioma	9.72e-05	0.000272	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2—malignant glioma	9.7e-05	0.000272	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STAT3—malignant glioma	9.7e-05	0.000272	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT2—malignant glioma	9.67e-05	0.000271	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PTEN—malignant glioma	9.67e-05	0.000271	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF2—malignant glioma	9.63e-05	0.00027	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CB—malignant glioma	9.6e-05	0.000269	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PDGFRA—malignant glioma	9.54e-05	0.000268	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—malignant glioma	9.43e-05	0.000264	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SPHK1—malignant glioma	9.4e-05	0.000264	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CD—malignant glioma	9.29e-05	0.00026	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPP1—malignant glioma	9.26e-05	0.00026	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCL8—malignant glioma	9.22e-05	0.000259	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2C18—malignant glioma	9.21e-05	0.000258	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PIK3CA—malignant glioma	9.18e-05	0.000257	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—malignant glioma	9.15e-05	0.000256	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IFNG—malignant glioma	9.06e-05	0.000254	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—malignant glioma	9.01e-05	0.000253	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MDM2—malignant glioma	9.01e-05	0.000253	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RAF1—malignant glioma	8.98e-05	0.000252	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—malignant glioma	8.96e-05	0.000251	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF2—malignant glioma	8.89e-05	0.000249	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ERBB2—malignant glioma	8.88e-05	0.000249	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—malignant glioma	8.87e-05	0.000249	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EGFR—malignant glioma	8.81e-05	0.000247	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—malignant glioma	8.81e-05	0.000247	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TERT—malignant glioma	8.78e-05	0.000246	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CB—malignant glioma	8.77e-05	0.000246	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—malignant glioma	8.73e-05	0.000245	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—malignant glioma	8.64e-05	0.000242	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PDGFB—malignant glioma	8.57e-05	0.00024	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGFR1—malignant glioma	8.53e-05	0.000239	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HIF1A—malignant glioma	8.4e-05	0.000235	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—malignant glioma	8.33e-05	0.000234	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KRAS—malignant glioma	8.33e-05	0.000234	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MDM2—malignant glioma	8.32e-05	0.000233	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RAF1—malignant glioma	8.29e-05	0.000233	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—malignant glioma	8.24e-05	0.000231	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ERBB2—malignant glioma	8.2e-05	0.00023	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—malignant glioma	8.16e-05	0.000229	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—COX8A—malignant glioma	8.15e-05	0.000229	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CAV1—malignant glioma	8.12e-05	0.000228	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CB—malignant glioma	8.09e-05	0.000227	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—malignant glioma	8.08e-05	0.000227	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EGFR—malignant glioma	8.06e-05	0.000226	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—malignant glioma	8.05e-05	0.000226	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—malignant glioma	8.03e-05	0.000225	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KDR—malignant glioma	8.03e-05	0.000225	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—malignant glioma	8.02e-05	0.000225	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EGFR—malignant glioma	7.86e-05	0.00022	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FN1—malignant glioma	7.73e-05	0.000217	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—F2—malignant glioma	7.73e-05	0.000217	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—malignant glioma	7.65e-05	0.000215	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BAD—malignant glioma	7.64e-05	0.000214	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KRAS—malignant glioma	7.62e-05	0.000214	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PTEN—malignant glioma	7.58e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH1—malignant glioma	7.57e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—malignant glioma	7.5e-05	0.00021	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTT1—malignant glioma	7.45e-05	0.000209	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KRAS—malignant glioma	7.42e-05	0.000208	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CD80—malignant glioma	7.41e-05	0.000208	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—malignant glioma	7.4e-05	0.000208	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APC—malignant glioma	7.4e-05	0.000207	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CG—malignant glioma	7.4e-05	0.000207	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGF—malignant glioma	7.31e-05	0.000205	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTPN11—malignant glioma	7.27e-05	0.000204	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—malignant glioma	7e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTEN—malignant glioma	6.99e-05	0.000196	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS1—malignant glioma	6.98e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BRAF—malignant glioma	6.95e-05	0.000195	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ASMT—malignant glioma	6.93e-05	0.000194	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—malignant glioma	6.82e-05	0.000191	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—malignant glioma	6.78e-05	0.00019	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—malignant glioma	6.77e-05	0.00019	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT2—malignant glioma	6.77e-05	0.00019	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EGFR—malignant glioma	6.74e-05	0.000189	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—malignant glioma	6.6e-05	0.000185	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BCAN—malignant glioma	6.52e-05	0.000183	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CD—malignant glioma	6.5e-05	0.000182	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BCHE—malignant glioma	6.49e-05	0.000182	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—malignant glioma	6.44e-05	0.000181	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC5A5—malignant glioma	6.41e-05	0.00018	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—KRAS—malignant glioma	6.37e-05	0.000179	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—malignant glioma	6.26e-05	0.000175	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—malignant glioma	6.25e-05	0.000175	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF2—malignant glioma	6.23e-05	0.000175	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGFR—malignant glioma	6.16e-05	0.000173	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—malignant glioma	5.85e-05	0.000164	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MDM2—malignant glioma	5.83e-05	0.000163	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KRAS—malignant glioma	5.82e-05	0.000163	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—malignant glioma	5.81e-05	0.000163	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RAF1—malignant glioma	5.81e-05	0.000163	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ERBB2—malignant glioma	5.74e-05	0.000161	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—malignant glioma	5.72e-05	0.00016	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGFR—malignant glioma	5.69e-05	0.000159	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CB—malignant glioma	5.67e-05	0.000159	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—malignant glioma	5.57e-05	0.000156	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL8—malignant glioma	5.45e-05	0.000153	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KRAS—malignant glioma	5.37e-05	0.000151	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—malignant glioma	5.34e-05	0.00015	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—malignant glioma	5.26e-05	0.000148	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—IDH2—malignant glioma	5.25e-05	0.000147	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—malignant glioma	5.21e-05	0.000146	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—malignant glioma	5.21e-05	0.000146	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTP1—malignant glioma	5.16e-05	0.000145	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAT—malignant glioma	5.02e-05	0.000141	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.94e-05	0.000138	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—malignant glioma	4.93e-05	0.000138	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—malignant glioma	4.93e-05	0.000138	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTEN—malignant glioma	4.9e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—malignant glioma	4.78e-05	0.000134	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NCOR1—malignant glioma	4.74e-05	0.000133	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—IDH1—malignant glioma	4.52e-05	0.000127	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—malignant glioma	4.42e-05	0.000124	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—malignant glioma	4.38e-05	0.000123	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SPHK1—malignant glioma	4.37e-05	0.000123	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—malignant glioma	4.37e-05	0.000122	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.28e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—malignant glioma	4.07e-05	0.000114	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—malignant glioma	4.03e-05	0.000113	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGFR—malignant glioma	3.98e-05	0.000112	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAV1—malignant glioma	3.87e-05	0.000108	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KRAS—malignant glioma	3.76e-05	0.000105	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CG—malignant glioma	3.52e-05	9.88e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTT1—malignant glioma	3.46e-05	9.71e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—malignant glioma	3.46e-05	9.69e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—malignant glioma	3.4e-05	9.54e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—malignant glioma	3.34e-05	9.38e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS1—malignant glioma	3.25e-05	9.1e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.1e-05	8.69e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BCHE—malignant glioma	3.02e-05	8.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.98e-05	8.36e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—malignant glioma	2.82e-05	7.92e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.7e-05	7.57e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—malignant glioma	2.67e-05	7.5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTP1—malignant glioma	2.4e-05	6.73e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAT—malignant glioma	2.34e-05	6.55e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTEN—malignant glioma	2.33e-05	6.54e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NCOR1—malignant glioma	2.21e-05	6.19e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAV1—malignant glioma	1.8e-05	5.04e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.65e-05	4.61e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.64e-05	4.59e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—malignant glioma	1.58e-05	4.43e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.44e-05	4.04e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—malignant glioma	1.34e-05	3.77e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.26e-05	3.52e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—malignant glioma	1.24e-05	3.49e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTEN—malignant glioma	1.08e-05	3.04e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.65e-06	2.15e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—malignant glioma	6.25e-06	1.75e-05	CbGpPWpGaD
